Identifying early brain changes linked to Alzheimer's disease

Quantification of microstructures in the entorhinal-hippocampus pathway as a sensitive biomarker for neurodegeneration during the preclinical stage of Alzheimer's disease

NIH-funded research Johns Hopkins University · NIH-10949187

This study is looking at tiny changes in the brain that could show early signs of Alzheimer's disease, helping us find ways to spot the condition before symptoms start, so we can take action sooner.

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University NIH-funded
Lab location1 site (Baltimore, United States)
Project IDNIH-10949187 on NIH RePORTER

What this research studies

This research investigates the early microstructural changes in the entorhinal-hippocampus pathway to identify sensitive biomarkers for neurodegeneration associated with Alzheimer's disease. By focusing on the preclinical stage of the disease, the study aims to develop tools that can predict cognitive decline before symptoms appear. The approach involves advanced neuroimaging techniques to detect subtle changes in brain structure that may indicate the onset of Alzheimer's. This could lead to earlier interventions and better management of the disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals at risk for Alzheimer's disease, particularly those in the preclinical stage without noticeable cognitive impairment.

Not a fit: Patients who are already experiencing significant cognitive decline or have a confirmed diagnosis of Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could enable earlier diagnosis and intervention for Alzheimer's disease, potentially slowing its progression.

How similar studies have performed: Previous research has shown promise in identifying biomarkers for Alzheimer's disease, but this specific approach focusing on the entorhinal-hippocampus pathway is relatively novel.

Where this research is happening

Baltimore, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndromeAlzheimer's DiseaseAlzheimer's disease biological markerAlzheimer's disease diagnostic
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.